attia glp 1 320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape GLP-1 Agonists For Obesity In

This has positioned it as a subject of interest in neurobiological research, particularly in studies examining neuroprotective mechanisms and central nervous system signalling

These findings could provide new insights into the risk-benefit ratio of using GLP-1 RAs in women of childbearing age who may need to discontinue their medication if they become pregnant in the future

Its anti-inflammatory effect appears to be largely independent of the melanocortin receptors and instead depends on the intestinal di/tripeptide transporter PepT1, which actively imports KPV into epithelial and immune cells where it can inhibit NF-B signaling and dampen production of pro-inflammatory cytokines such as TNF-, IL-1, and IL-6

You asked for it, and weve got it